• Multiple Myeloma

“Her research focuses on precursor conditions of multiple myeloma, aiming to understand genetic, epigenetic, and immune mechanisms of disease progression, identify novel biomarkers, and develop therapies to eliminate disease before progression. She developed the PCROWD Study, a large, patient-empowering observational study for these precursor conditions, and the PROMISE Study, which screens high-risk individuals, including those of African descent or with a family history of blood cancer. Dr. Ghobrial earned her medical degree from Cairo University School of Medicine, Egypt. She completed her residency in Internal Medicine at Wayne State University, Michigan, and Hematology/Oncology Fellowship at the Mayo Clinic College of Medicine, Minnesota, before joining Dana-Farber in 2004.”